Hi fyffee
Also extracted from the announcement:
"Matthew Lehman, Prima’s CEO: “We are very pleased to have received approval for the CAN-004
protocol amendment in Belgium, and we anticipate other regulators will soon follow. It is exciting that
we will soon be able to re-start recruitment of the CVac clinical trial for ovarian cancer.”
__________________________________________________
The trial will require patients to be recruited from USA and several countries in Europe, so they will need to have approval for the trial protocol from those jurisdictions prior to recruiting patients.
Cheers
K
announcement out, page-36
Add IMM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
29.0¢ |
Change
0.020(7.41%) |
Mkt cap ! $421.8M | |||
| Open | High | Low | Value | Volume |
| 27.5¢ | 29.5¢ | 27.0¢ | $1.138M | 3.985M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 63444 | 28.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 29.5¢ | 65000 | 2 |
View Market Depth
| Last trade - 16.10pm 08/11/2024 (20 minute delay) ? |
| IMM (ASX) Chart |